You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FAMOTIDINE AND IBUPROFEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Famotidine And Ibuprofen, and what generic alternatives are available?

Famotidine And Ibuprofen is a drug marketed by Torrent and is included in one NDA.

The generic ingredient in FAMOTIDINE AND IBUPROFEN is famotidine; ibuprofen. There are eighteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the famotidine; ibuprofen profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Famotidine And Ibuprofen

A generic version of FAMOTIDINE AND IBUPROFEN was approved as famotidine; ibuprofen by ENDO OPERATIONS on March 22nd, 2024.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FAMOTIDINE AND IBUPROFEN?
  • What are the global sales for FAMOTIDINE AND IBUPROFEN?
  • What is Average Wholesale Price for FAMOTIDINE AND IBUPROFEN?
Summary for FAMOTIDINE AND IBUPROFEN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 6
DailyMed Link:FAMOTIDINE AND IBUPROFEN at DailyMed
Drug patent expirations by year for FAMOTIDINE AND IBUPROFEN
Recent Clinical Trials for FAMOTIDINE AND IBUPROFEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 4
Pediatric Rheumatology Collaborative Study GroupPhase 4
Horizon Pharma Ireland, Ltd., Dublin IrelandPhase 4

See all FAMOTIDINE AND IBUPROFEN clinical trials

US Patents and Regulatory Information for FAMOTIDINE AND IBUPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent FAMOTIDINE AND IBUPROFEN famotidine; ibuprofen TABLET;ORAL 215925-001 Mar 18, 2024 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.